Candida albicans exposures, sex specificity and cognitive deficits in schizophrenia and bipolar disorder

被引:91
|
作者
Severance E.G. [1 ]
Gressitt K.L. [1 ]
Stallings C.R. [2 ]
Katsafanas E. [2 ]
Schweinfurth L.A. [2 ]
Savage C.L. [2 ]
Adamos M.B. [2 ]
Sweeney K.M. [2 ]
Origoni A.E. [2 ]
Khushalani S. [2 ]
Leweke F.M. [3 ]
Dickerson F.B. [2 ]
Yolken R.H. [1 ]
机构
[1] Stanley Division of Developmental Neurovirology, Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, MD
[2] Sheppard Pratt Health System, Stanley Research Program, Baltimore, MD
[3] Department of Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Mannheim
来源
npj Schizophrenia | / 2卷 / 1期
关键词
D O I
10.1038/npjschz.2016.18
中图分类号
学科分类号
摘要
Immune aberrations in schizophrenia and bipolar disorder have led to the hypotheses that infectious agents or corresponding immune responses might contribute to psychiatric etiopathogeneses. We investigated case-control differences in exposure to the opportunistic fungal pathogen, Candida albicans, and examined associations with cognition, medication, lifestyle, and somatic conditions. We quantified C. albicans IgG antibodies in two cohorts totaling 947 individuals and evaluated odds ratios (OR) of exposure with psychiatric disorder using multivariate regressions. The case-control cohort included 261 with schizophrenia, 270 with bipolar disorder, and 277 non-psychiatric controls; the second included 139 with first-episode schizophrenia, 78 of whom were antipsychotic naive. No differences in C. albicans exposures were found until diagnostic groups were stratified by sex. In males, C. albicans seropositivity conferred increased odds for a schizophrenia diagnosis (OR 2.04-9.53, P 1/20.0001). In females, C. albicans seropositivity conferred increased odds for lower cognitive scores on Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) in schizophrenia (OR 1.12, P 1/20.004), with significant decreases on memory modules for both disorders (P 1/20.0007-0.03). C. albicans IgG levels were not impacted by antipsychotic medications. Gastrointestinal (GI) disturbances were associated with elevated C. albicans in males with schizophrenia and females with bipolar disorder (P 1/20.009-0.02). C. albicans exposure was associated with homelessness in bipolar males (P 1/20.0015). In conclusion, sex-specific C. albicans immune responses were evident in psychiatric disorder subsets. Inquiry regarding C. albicans infection or symptoms may expedite amelioration of this treatable comorbid condition. Yeast exposure as a risk factor for schizophrenia and its associated cognitive and GI effects require further investigation including the possible contribution of gut-brain mechanisms.
引用
收藏
相关论文
共 50 条
  • [41] Neuroanatomical Dysconnectivity Underlying Cognitive Deficits in Bipolar Disorder
    McPhilemy, Genevieve
    Nabulsi, Leila
    Kilmartin, Liam
    O'Hora, Denis
    O'Donoghue, Stefani
    Tronchin, Giulia
    Costello, Laura
    Najt, Pablo
    Ambati, Srinath
    Neilsen, Grainne
    Creighton, Sarah
    Byrne, Fintan
    McLoughlin, James
    McDonald, Colm
    Hallahan, Brian
    Cannon, Dara M.
    BIOLOGICAL PSYCHIATRY-COGNITIVE NEUROSCIENCE AND NEUROIMAGING, 2020, 5 (02) : 152 - 162
  • [42] Galantamine-ER for cognitive deficits in bipolar disorder
    Iosifescu, D. V.
    Murrough, J. W.
    Deckersbach, T.
    Iacoviello, B.
    Huryk, K.
    Nierenberg, A. A.
    BIPOLAR DISORDERS, 2015, 17 : 57 - 57
  • [43] Cognitive deficits observed in patients with euthymic bipolar disorder
    不详
    CNS SPECTRUMS, 2007, 12 (10) : 737 - 738
  • [44] Galantamine-ER for Cognitive Deficits in Bipolar Disorder
    Losifescu, Dan V.
    Murrough, James W.
    Deckersbach, Thilo
    Parides, Michael
    Iacoviello, Brian
    Nierenberg, Andrew A.
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 70S - 70S
  • [45] Similarities and differences between multivariate patterns of cognitive and socio-cognitive deficits in schizophrenia, bipolar disorder and related risk
    Alessandra Raio
    Giulio Pergola
    Antonio Rampino
    Marianna Russo
    Enrico D’Ambrosio
    Pierluigi Selvaggi
    Valerie De Chiara
    Mario Altamura
    Flora Brudaglio
    Alessandro Saponaro
    Domenico Semisa
    Alessandro Bertolino
    Linda A. Antonucci
    Giuseppe Blasi
    Schizophrenia, 9
  • [46] Similarities and differences between multivariate patterns of cognitive and socio-cognitive deficits in schizophrenia, bipolar disorder and related risk
    Raio, Alessandra
    Pergola, Giulio
    Rampino, Antonio
    Russo, Marianna A.
    D'Ambrosio, Enrico
    Selvaggi, Pierluigi
    De Chiara, Valerie
    Altamura, Mario
    Brudaglio, Flora
    Saponaro, Alessandro
    Semisa, Domenico
    Bertolino, Alessandro
    Antonucci, Linda
    Blasi, Giuseppe
    SCHIZOPHRENIA, 2023, 9 (01)
  • [47] Cognitive control deficits in patients with schizophrenia, bipolar I disorder and unaffected first-degree relatives
    Yun, Hyerim
    Woo, Sunjin
    Koo, Taehoon
    Lee, Sangwon
    Won, Seunghee
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 245 - 246
  • [48] Schizophrenia, Bipolar Disorder and Pre-Attentional Inhibitory Deficits
    Vlcek, Premysl
    Bob, Petr
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 821 - 827
  • [49] Differential Deficits in Facial Emotion Recognition in Schizophrenia and Bipolar Disorder
    Goghari, Vina M.
    Sponheim, Scott R.
    BIOLOGICAL PSYCHIATRY, 2011, 69 (09) : 243S - 243S
  • [50] Deficits in gray matter volume are present in schizophrenia but not bipolar disorder
    Zipursky, RB
    Seeman, MV
    Bury, A
    Langevin, R
    Wortzman, G
    Katz, R
    SCHIZOPHRENIA RESEARCH, 1997, 26 (2-3) : 85 - 92